| |
| |
|
| Insider
Information: |
Szyman Catherine M |
| Relationship: |
Director |
| City: |
Minneapolis |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
90,399 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,335,527 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,399 |
|
|
| Total
Value |
$1,335,527 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 52.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Edwards Lifesciences Corp |
EW |
CVP, Critical Care |
2024-02-22 |
43,374 |
2019-08-30 |
0 |
Premium* |
|
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
22,429 |
2020-05-27 |
0 |
Premium* |
|
|
Outset Medical, Inc. |
OM |
Director |
2023-05-31 |
24,596 |
2021-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2024-04-24 |
4 |
A |
$42.41 |
$174,984 |
D/D |
4,126 |
22,429 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
8,560 |
43,374 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2024-02-15 |
4 |
S |
$85.62 |
$2,311,654 |
D/D |
(27,000) |
34,814 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2024-02-15 |
4 |
OE |
$36.75 |
$992,250 |
D/D |
27,000 |
61,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2024-02-13 |
4 |
OE |
$36.75 |
$735,000 |
D/D |
20,000 |
54,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2024-02-13 |
4 |
S |
$86.46 |
$1,729,200 |
D/D |
(20,000) |
34,814 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-10-10 |
4 |
AS |
$72.68 |
$363,400 |
D/D |
(5,000) |
34,814 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-10-10 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-09-08 |
4 |
AS |
$76.00 |
$380,000 |
D/D |
(5,000) |
34,814 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-09-08 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-08-09 |
4 |
AS |
$78.64 |
$393,185 |
D/D |
(5,000) |
34,814 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-08-09 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-07-10 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-07-10 |
4 |
AS |
$90.52 |
$452,600 |
D/D |
(5,000) |
34,814 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-07-07 |
4 |
D |
$90.46 |
$22,796 |
D/D |
(252) |
34,814 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-06-13 |
4 |
AS |
$85.81 |
$429,045 |
D/D |
(5,000) |
35,056 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-06-13 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
40,056 |
0 |
- |
|
| OM |
Outset Medical, Inc. |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,681 |
24,596 |
0 |
- |
|
| NARI |
Inari Medical, Inc. |
Director |
• • – |
2023-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,412 |
18,303 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,525 |
35,056 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-05-09 |
4 |
OE |
$35.20 |
$2,660,871 |
D/D |
75,600 |
104,131 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-05-09 |
4 |
AS |
$88.94 |
$6,724,234 |
D/D |
(75,600) |
28,531 |
0 |
% |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-05-08 |
4 |
D |
$88.74 |
$122,106 |
D/D |
(1,376) |
28,531 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-05-07 |
4 |
D |
$88.74 |
$191,146 |
D/D |
(2,154) |
29,907 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
• • – |
2023-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,708 |
32,061 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
